![](https://beyondspringpharma.com/wp-content/uploads/2022/02/SABCS-Logo.png)
12.2020
Annual San Antonio Breast Cancer Symposium
Protective 2 (BPI 2358 106): a Confirmatory Trial to Demonstrate Superiority of the Plinabulin (Plin) + Pegfilgrastim (Peg) Comb ination versus Standard of Care Pegfilgrastim for the Prevention of Chemotherapy Induced Neutropenia in Breast Cancer Patients.